Boston Scientific ACURATE neo2 Aortic Valve System delivers procedural success rate of 98%
Boston Scientific said that the ACURATE neo2 Aortic Valve System delivered a high procedural success rate of 98.4% and low rates of paravalvular leak (PVL) and mortality in a post-market study. The findings are part of the first results from the ACURATE neo2 post market clinical follow-up (PMCF) study that is assessing the performance of […]